VIVOSIM LABS INC. - COMMON STOCK

VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer

06 Jan 2026 08:05:00 By Nasdaq GlobeNewswire

VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer

14 Aug 2025 08:05:12 By Nasdaq GlobeNewswire

VivoSim’s NAMKind™ Intestine Wins Blue Ribbon Award at Digestive Disease Week Conference

13 May 2025 08:05:27 By Nasdaq GlobeNewswire

VivoSim Presents Best-in-Class Liver Toxicology Prediction Results at Digestive Disease Week Conference

07 May 2025 08:05:00 By Nasdaq GlobeNewswire

VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market

24 Apr 2025 08:05:11 By Nasdaq GlobeNewswire

VivoSim to Carry Forward Organovo 3D Bioprinting

23 Apr 2025 08:05:21 By Nasdaq GlobeNewswire

Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements

02 Apr 2025 08:05:00 By Nasdaq GlobeNewswire

Organovo Provides Business Update

27 Mar 2025 08:05:27 By Nasdaq GlobeNewswire

Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company

25 Mar 2025 11:25:12 By Nasdaq GlobeNewswire